Issue 36 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

25

No.

36

September 24, 1999Sep 24, 1999

Free

DOWNLOAD THE PDF

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

In Brief: Justice Department Files Civil Suit To recover $25 Billion From Tobacco

ODAC Actions: Large Subset analysis Of CALGB Study Was Basis for BMS Taxol Application

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

Roferon A Application Marred By Mission Data, Protocol, Compliance

Underpowered Study Of Evacet Dashes Approval Hopes

NCI Programs: Institute Funds 24 DNA Microarray Centers

Recent Issues

Volume 51 | Issue 32 - September 05, 2025

Volume 51 | Issue 31 - August 08, 2025

Volume 51 | Issue 30 - August 01, 2025

Volume 51 | Issue 29 - July 25, 2025

Volume 51 | Issue 28 - July 18, 2025

Volume 51 | Issue 27 - July 11, 2025